Christopher Ellis insider trades: Vaccitech (VACC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christopher reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 25, 2022 | VACC | ↓ Sell | 39,626 | $6.55 | $260K | Direct | Aug 26, 2022 (1d) |
| Aug 18, 2022 | VACC | ↓ Sell | 2,824 | $4.82 | $14K | Direct | Aug 19, 2022 (1d) |
| Aug 16, 2022 | VACC | ↓ Sell | 7,550 | $4.77 | $36K | Direct | Aug 17, 2022 (1d) |
| Jun 28, 2022 | VACC | ↓ Sell | 5 | $6.00 | $30 | Direct | Jul 15, 2022 (17d) |
| May 4, 2021 | VACC | ↑ Buy | 75 | $17.00 | $1K | Direct | May 6, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Christopher Ellis's insider trades
Christopher Ellis is Chief Operating Officer at Vaccitech (VACC). Since May 4, 2021, Christopher has reported 1 open-market purchase worth $1K and 4 sales worth $309K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (4 filings), grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VACC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.